Controlled release dosage form having improved drug release properties
作者： John W. Skoug , Stephen L. Secreast , Anthony J. Hlinak , Ahmad M. Mazhary , Jackie G. White
DOI:
关键词:
摘要: Controlled release pharmaceutical compositions comprising tolterodine and a polymer-based release-controlling component processes for preparing such are provided. The useful in the treatment of overactive bladder similar conditions.
lens.org参考文章(10)
Douglas Ellis Leng, Wilmer List Sigelko, Frank Linwood Sounders, Aqueous dispersions of plasticized polymer particles ,(1983)
William Thomas Muldoon, James Albert Napper, Susan Marie Milosovich, Laurence Rousseau, Joseph Peter Sauer, Controlled release dosage form of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2]oct-3-yl)acetonitrile monohydrochloride ,(2001)
Martin Wikberg, Torkek Gren, Jan Strombom, Anders Ringberg, Lisbeth Nilvebrant, Bengt Hallen, Birgitta Olsson, Pharmaceutical formulation and its use ,(2000)
Martin Wikberg, Anders Ringberg, Torkel Gren, Jan Strombom, Lisbeth Nilvebrant, Bengt Hallen, Birgitta Olsson, Pharmaceutical formulation containing tolterodine and its use ,(2000)
Eric H. Kuhrts, Delivery system containing a gel-forming dietary fiber and a drug ,(1993)
Vladimir Kaplan, William H. Smith, Robert E. Cates, Katherine K. Flamm, Edward N. Schinner, Cooling tower strainer tank and screen ,(1991)
Mott Steven R Le, Richard W Korsmeyer, William John Curatolo, Hylar L Friedman, Controlled-release dosage forms of azithromycin ,(1995)
Rolf Arne Johansson, Bengt Åke Sparf, Pinchas Moses, Lisbeth Nilvebrant, 3,3-Diphenylpropylamines, their use and preparation ,(1993)
Frank Pedi, Benjamin Oshlack, Mark Chasin, Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer ,(1992)
Anand R. Baichwal, Sustained release heterodisperse hydrogel systems--amorphous drugs ,(1997)